Rare bleeding disorders: Diagnosis and treatment

Blood

Volumn 125, Issue 13, 2015, Pages 2052-2061

  Palla, Roberta ^a   Peyvandi, Flora ^a   Shapiro, Amy D ^b,c  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b INDIANA HEMOPHILIA AND THROMBOSIS CENTER   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX;

BLEEDING DISORDER; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD CLOTTING TEST; BLOOD SUBSTITUTION; DELAYED DIAGNOSIS; DISEASE CLASSIFICATION; EMPLOYMENT; ENDOMETRIOSIS; ENDOMETRIUM HYPERPLASIA; FIBRINOGEN DEFECT; HEMOPHILIA A; HEMOSTASIS; HUMAN; LABORATORY DIAGNOSIS; MOLECULAR DIAGNOSIS; MORBIDITY; MORTALITY; NONHUMAN; OVARY CYST; POSTPARTUM HEMORRHAGE; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN DEFICIENCY; QUALITY OF LIFE; RARE DISEASE; REVIEW; SPONTANEOUS ABORTION; BLOOD EXAMINATION; DIAGNOSTIC PROCEDURE; GENETICS; HEMORRHAGIC DISORDERS; PROCEDURES; RARE DISEASES;

CLINICAL LABORATORY TECHNIQUES; HEMATOLOGIC TESTS; HEMORRHAGIC DISORDERS; HEMOSTASIS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; RARE DISEASES;

EID: 84926150235     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-08-532820     Document Type: Review

References (60)

1. Peyvandi F, Palla R, Menegatti M, Mannucci PM. Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management. Semin Thromb Hemost. 2009; 35(4):349-355.
2. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood. 2004; 104(5):1243-1252.
3. Borhany M, Pahore Z, Ul Qadr Z, et al. Bleeding disorders in the tribe: result of consanguineous in breeding. Orphanet J Rare Dis. 2010;5:23.
4. Jaouad IC, Elalaoui SC, Sbiti A, Elkerh F, Belmahi L, Sefiani A. Consanguineous marriages in Morocco and the consequence for the incidence of autosomal recessive disorders. J Biosoc Sci. 2009;41(5):575-581.
5. Saadat M, Ansari-Lari M, Farhud DD. Consanguineous marriage in Iran. Ann Hum Biol. 2004;31(2):263-269.
6. Peretz H, Mulai A, Usher S, et al. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin. Blood. 1997;90(7):2654-2659.
7. Karimi M, Haghpanah S, Amirhakimi A, Afrasiabi A, Dehbozorgian J, Nasirabady S. Spectrum of inherited bleeding disorders in southern Iran, before and after the establishment of comprehensive coagulation laboratory. Blood Coagul Fibrinolysis. 2009;20(8):642-645.
8. Viswabandya A, Baidya S, Nair SC, et al. Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India. Haemophilia. 2012;18(3): e195-e200.
9. de Moerloose P, Casini A, Neerman-Arbez M. Congenital fibrinogen disorders: an update. Semin Thromb Hemost. 2013;39(6):585-595.
10. Lancellotti S, Basso M, De Cristofaro R. Congenital prothrombin deficiency: an update. Semin Thromb Hemost. 2013;39(6):596-606.
11. Thalji N, Camire RM. Parahemophilia: new insights into factor v deficiency. Semin Thromb Hemost. 2013;39(6):607-612.
12. Zheng C, Zhang B. Combined deficiency of coagulation factors V and VIII: an update. Semin Thromb Hemost. 2013;39(6):613-620.
13. Mariani G, Bernardi F. Factor VII Deficiency. Semin Thromb Hemost. 2009;35(4):400-406.
14. Menegatti M, Peyvandi F. Factor X deficiency. Semin Thromb Hemost. 2009;35(4):407-415.
15. Duga S, Salomon O. Congenital factor XI deficiency: an update. Semin Thromb Hemost. 2013;39(6):621-631.
16. Schroeder V, Kohler HP. Factor XIII deficiency: an update. Semin Thromb Hemost. 2013;39(6): 632-641.
17. Peyvandi F, Palla R, Menegatti M. European registry of rare bleeding disorders. Hematology Education: the education programme for the annual congress of the European Hematology Association 2010;4:63-68. Available online at http://www.ehaweb.org.
18. Karimi M, Menegatti M, Afrasiabi A, Sarikhani S, Peyvandi F. Phenotype and genotype report on homozygous and heterozygous patients with congenital factor X deficiency. Haematologica. 2008;93(6):934-938.
19. Mariani G, Herrmann FH, Dolce A, et al International Factor VII Deficiency Study Group. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost. 2005;93(3):481-487.
20. James AH. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia. 2005;11(4): 295-307.
21. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. 1998;351(9101):485-489.
22. Kouides PA, Phatak PD, Burkart P, et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia. 2000;6(6): 643-648.
23. Ruiz-Saez A. Occurrence of thrombosis in rare bleeding disorders. Semin Thromb Hemost. 2013; 39(6):684-692.
24. Peyvandi F, Palla R, Menegatti M, et al European Network of Rare Bleeding Disorders Group. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost. 2012;10(4):615-621.
25. nd ed. https://www.wfh.org/ en/page.aspx?pid5877. Accessed July 28, 2014.
26. Muszbek L, Bagoly Z, Cairo A, Peyvandi F. Novel aspects of factor XIII deficiency. Curr Opin Hematol. 2011;18(5):366-372.
27. Ajzner E, Muszbek L. Kinetic spectrophotometric factor XIII activity assays: the subtraction of plasma blank is not omissible [corrected]. J Thromb Haemost. 2004;2(11):2075-2077.
28. Kohler HP, Ichinose A, Seitz R, Ariens RA, Muszbek L; Factor XIII And Fibrinogen SSC Subcommittee Of The ISTH. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost. 2011;9(7):1404-1406.
29. Peyvandi F, Kunicki T, Lillicrap D. Genetic sequence analysis of inherited bleeding diseases. Blood. 2013;122(20):3423-3431.
30. Al Dieri R, Peyvandi F, Santagostino E, et al. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost. 2002;88(4):576-582.
31. Van Geffen M, Menegatti M, Loof A, et al. Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders. Haemophilia. 2012;18(4):630-638.
32. Strey RF, Siegemund A, Siegemund T, et al. Influence of factor V HR2 on thrombin generation and clinical manifestation in rare bleeding disorders. Pathophysiol Haemost Thromb. 2005; 34(6):279-283.
33. Spiezia L, Radu C, Campello E, et al. Whole blood rotation thromboelastometry (ROTEM(-)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. Haemophilia. 2012;18(3):463-468.
34. Rugeri L, Qú elin F, Chatard B, De Mazancourt P, Negrier C, Dargaud Y. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk. Haemophilia. 2010;16(5):771-777.
35. Mumford AD, Ackroyd S, Alikhan R, et al BCSH Committee. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2014;167(3):304-326.
36. Keeling D, Tait C, Makris M. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology. Haemophilia. 2008;14(4):671-684.
37. Soucie JM, McAlister S, McClellan A, Oakley M, Su Y. The universal data collection surveillance system for rare bleeding disorders. Am J Prev Med. 2010;38(4 Suppl):S475-S481.
38. Makris M, Calizzani G, Fischer K, et al. EUHASS: The European Haemophilia Safety Surveillance system. Thromb Res. 2011;127(Suppl 2): S22-S25.
39. Shapiro AD, Peyvandi F. Rare Coagulation Disorders Resource Room. Available at: https:// www.rarecoagulationdisorders.org/. Accessed July 28, 2014.
40. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol. 1999; 107(1):204-206.
41. Acharya SS, Coughlin A, Dimichele DM; North American Rare Bleeding Disorder Study Group. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost. 2004; 2(2):248-256.
42. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126(1):11-28.
43. Sørensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol. 2010;149(6):834-843.
44. Peyvandi F, Palla R. Fibrinogen concentrates. Clin Adv Hematol Oncol. 2009;7(12):788-790.
45. Lechler E. Use of prothrombin complex concentrates for prophylaxis and treatment of bleeding episodes in patients with hereditary deficiency of prothrombin, factor VII, factor X, protein C protein S, or protein Z. Thromb Res. 1999;95(4 Suppl 1):S39-S50.
46. Di Paola J, Nugent D, Young G. Current therapy for rare factor deficiencies. Haemophilia. 2001; 7(Suppl 1):16-22.
47. Ragni MV, Lewis JH, Spero JA, Hasiba U. Factor VII deficiency. Am J Hematol. 1981;10(1):79-88.
48. Mariani G, Herrmann FH, Schulman S, et al International Factor VII Deficiency Study Group. Thrombosis in inherited factor VII deficiency. J Thromb Haemost. 2003;1(10):2153-2158.
49. Napolitano M, Giansily-Blaizot M, Dolce A, et al. Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER). Haematologica. 2013;98(4):538-544.
50. Baumann Kreuziger LM, Morton CT, Reding MT. Is prophylaxis required for delivery in women with factor VII deficiency? Haemophilia. 2013;19(6): 827-832.
51. Karimi M, Vafafar A, Haghpanah S, et al. Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran. Haemophilia. 2012;18(2):211-215.
52. Myers B, Pavord S, Kean L, Hill M, Dolan G. Pregnancy outcome in Factor XI deficiency: incidence of miscarriage, antenatal and postnatal haemorrhage in 33 women with Factor XI deficiency. BJOG. 2007;114(5):643-646.
53. Salomon O, Steinberg DM, Seligshon U. Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy. Haemophilia. 2006;12(5): 490-493.
54. Kravtsov DV, Wu W, Meijers JC, et al. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood. 2004;104(1): 128-134.
55. Zucker M, Seligsohn U, Salomon O, Wolberg AS. Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency. J Thromb Haemost. 2014; 12(7):1121-1130.
56. Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII Deficiency. Semin Thromb Hemost. 2009;35(4):426-438.
57. Perez DL, Diamond EL, Castro CM, et al. Factor XIII deficiency related recurrent spontaneous intracerebral hemorrhage: a case and literature review. Clin Neurol Neurosurg. 2011;113(2): 142-145.
58. Sharief LA, Kadir RA. Congenital factor XIII deficiency in women: a systematic review of literature. Haemophilia. 2013;19(6):e349-e357.
59. Caudill JS, Nichols WL, Plumhoff EA, et al. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Transfusion. 2009;49(4):765-770.
60. Brenner B, Kuperman AA, Watzka M, Oldenburg J. Vitamin K-dependent coagulation factors deficiency. Semin Thromb Hemost. 2009;35(4): 439-446.